A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)
dc.contributor.author | Yurdaydin, Cihan | |
dc.contributor.author | Wedemeyer, Heiner | |
dc.contributor.author | Dalekos, George | |
dc.contributor.author | Erhardt, Alexander | |
dc.contributor.author | Cakaloglu, Ya | |
dc.contributor.author | Degertekin, Ha | |
dc.contributor.author | Gurel, Sa. | |
dc.date.accessioned | 2024-04-24T17:49:55Z | |
dc.date.available | 2024-04-24T17:49:55Z | |
dc.date.issued | 2006 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 27-31, 2006 -- Boston, MA | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.endpage | 230A | en_US |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 230A | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/23095 | |
dc.identifier.volume | 44 | en_US |
dc.identifier.wos | WOS:000241362300112 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | John Wiley & Sons Inc | en_US |
dc.relation.ispartof | Hepatology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT) | en_US |
dc.title | A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT) | |
dc.type | Conference Object | en_US |